Nature Medicine | Spoonful of Medicine

Pharma backs latest attempt at a global health R&D treaty

The World Health Organization (WHO) kicks off its annual meeting in Geneva next Monday, and one of the most contentious issues on the agenda will undoubtedly be a proposed agreement to fund the development of drugs for diseases that overwhelmingly afflict the world’s poor. The proposal, outlined today in PLoS Medicine, would require the WHO’s 193 member states to commit to increase government funding for global health initiatives from the $3 billion or so spent worldwide today to more than $6 billion annually in the near-future. 


Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.